Compensatory enlargement in transplant coronary artery disease: An intravascular ultrasound study

Chinese Medical Journal

Volumn 119, Issue 7, 2006, Pages 564-569

  Li, Hai Yan ^a,b   Tanaka, Koji ^a   Oeser, Brandy ^a   Wertman, Brett ^a   Kobashigawa, Jon A ^a   Tobis, Jonathan M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Compensatory enlargement; Intravascular ultrasound; Transplant coronary artery disease

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; GLYCERYL TRINITRATE; HEPARIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; DRUG DERIVATIVE; MYCOPHENOLIC ACID;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DOUBLE BLIND PROCEDURE; FEMALE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; INTRAOPERATIVE PERIOD; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POSTOPERATIVE PERIOD; PREDICTION; RANDOMIZED CONTROLLED TRIAL; ROC CURVE; SENSITIVITY AND SPECIFICITY; AGED; CORONARY BLOOD VESSEL; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; HYPERPLASIA; INTIMA; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AZATHIOPRINE; CORONARY DISEASE; CORONARY VESSELS; FEMALE; HEART TRANSPLANTATION; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; TUNICA INTIMA; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 33646838031     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200604010-00008     Document Type: Article

References (21)

1. Taylor DO, Edwards LB, Boucek MM, Trulock EP, Keck BM, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report-2004. J Heart Lung Transplant 2004;23:796-803.
2. Pinney SP, Mancini D. Cardiac allograft vasculopathy: advances in understanding its pathophysiology, prevention, and treatment. Curr Opin Cardiol 2004;19:170-176.
3. Nissen SE, Yock P. Intravascular ultrasound: novel pathophysiological insights and current clinical applications. Circulation 2001;103:604-616.
4. Weis M, von Scheidt W. Cardiac allograft vasculopathy: a review. Circulation 1997;96:2069-2077.
5. Ward MR, Pasterkamp G, Yeung AC, Borst C. Arterial remodeling. Mechanism and clinical implication. Circulation 2000;102:1186-1191.
6. Schoenhagen P, Ziada KM, Vince DG, Nissen SE, Tuzcu EM. Arterial remodeling and coronary artery disease: the concept of "dilated" versus "obstructive" coronary atherosclerosis. J Am Coll Cardiol 2001;38:297-306.
7. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987; 316:1371-1375.
8. Lim TT, Liang DH, Botas J, Schroeder JS, Oesterle SN, Yeung AC. Role of compensatory enlargement and shrinkage in transplant coronary artery disease. Serial intravascular ultrasound study. Circulation 1997; 95:855-859.
9. Pethig K, Heublein B, Meliss RR, Haverich A. Volumetric remodeling of the proximal left coronary artery: early versus late after heart transplantation. J Am Coll Cardiol 1999;34:197-203.
10. Kobashigawa J, Wener L, Johnson J, Currier JW, Yeatman L, Cassem J, et al. Longitudinal study of vascular remodeling in coronary arteries after heart transplantation. J Heart Lung Transplant 2000;19: 546-550.
11. Tsutsui H, Ziada KM, Schoenhagen P, Lyisoy A, Magyar WA, Crowe TD, et al. Lumen loss in transplant coronary artery disease is a biphasic process involving early intimal thickening and late constrictive remodeling: results from a 5-year serial intravascular ultrasound study. Circulation 2001;104:653-657.
12. Mainigi SK, Goldberg LR, Sasseen BM, See VY, Wilensky RL. Relative contributions of intimal hyperplasia and vascular remodeling in early cardiac transplant-mediated coronary artery disease. Am J Cardiol 2003;91:293-296.
13. Kobashigawa J, Miller L, Renlund D, Mentzer R, Alderman E, Bourge R, et al. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators. Transplantation 1998;66:507-515.
14. Jeremias A, Spies C, Herity NA, Ward MR, Pomerantsev E, Yock PG, et al. Coronary artery distensibility and compensatory vessel enlargement - a novel parameter influencing vascular remodeling? Basic Res Cardiol 2001;96:506-512.
15. Weis M, Pehlivanli S, von Scheidt W. Cardiac allograft endothelial dysfunction: cause, course, and conesquences. Z Kardiol 2000;89:IX58-62.
16. Billingham ME. Histopathology of graft coronary disease. J Heart Lung Transplant 1992;11:S38-S44.
17. Schwarzacher SP, Uren NG, Ward MR, Schwarzkopf A, Giannetti N, Hunt S, et al. Determinants of coronary remodeling in transplant coronary disease: a simultaneous intravascular ultrasound and Doppler flow study. Circulation 2000;101:1384-1389.
18. Wong C, Yeung AC. The topography of intimal thickening and associated remodeling pattern of early transplant coronary disease: influence of pre-existent donor atherosclerosis. J Heart Lung Transplant 2001;20:858-864.
19. Barten MJ, van Gelder T, Gummert JF, Boeke K, Shorthouse R, Billingham ME, et al. Pharmacodynamics of mycophenolate mofetil after heart transplantation: new mechanisms of action and correlations with histologic severity of graft rejection. Am J Transplant 2002;2:719-732.
20. Weigel G, Griesmacher A, Karimi A, Zuckermann AO, Grimm M, Mueller MM. Effect of mycophenolate mofetil therapy on lymphocyte activation in heart transplant recipients. J Heart Lung Transplant 2002;21:1074-1079.
21. Pethig K, Heublein B, Wahlers T, Dannenberg O, Oppelt P, Haverich A. Mycophenolate mofetil for secondary prevention of cardiac allograft vasculopathy: influence on inflammation and progression of intimal hyperplasia. J Heart Lung Transplant 2004;23:61-66.